These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15015980)

  • 1. Use of recombinant factor VIIa in inherited platelet disorders.
    Kaleelrahman M; Minford A; Parapia LA
    Br J Haematol; 2004 Apr; 125(1):95-6. PubMed ID: 15015980
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital and acquired platelet disorders: current dilemmas and treatment strategies.
    White GC
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S37-41. PubMed ID: 16427384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():37-40. PubMed ID: 12214146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of recombinant factor VIIa in children with inherited platelet function disorders.
    Almeida AM; Khair K; Hann I; Liesner R
    Br J Haematol; 2003 May; 121(3):477-81. PubMed ID: 12716372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
    Valentino LA
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
    Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
    Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa.
    Peters M; Heijboer H
    Thromb Haemost; 1998 Aug; 80(2):352. PubMed ID: 9716174
    [No Abstract]   [Full Text] [Related]  

  • 9. Glanzmann thrombasthenia successfully operated for nasal deformation with recombinant factor VIIA.
    Bay A; Oner AF
    Indian Pediatr; 2006 Dec; 43(12):1094. PubMed ID: 17202611
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
    Poon MC; d'Oiron R; Hann I; Négrier C; de Lumley L; Thomas A; Karafoulidou A; Demers C; Street A; Huth-Kühne A; Petrini P; Fressinaud E; Morfini M; Tengborn L; Marquès-Verdier A; Musso R; Devecioglu O; Houston DS; Lethagen S; Van Geet C; von Depka M; Berger C; Beurrier P; Britton HA; Gerrits W; Guthner C; Kuhle S; Lorenzo JJ; Makris PE; Nohe N; Paugy P; Pautard B; Torchet MF; Trillot N; Vicariot M; Wilde J; Winter M; Chambost H; Ingerslev J; Peters M; Strauss G
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):21-5. PubMed ID: 11735106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.
    Monroe DM; Hoffman M; Allen GA; Roberts HR
    Semin Thromb Hemost; 2000; 26(4):373-7. PubMed ID: 11092211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia.
    Chuansumrit A; Suwannuraks M; Sri-Udomporn N; Pongtanakul B; Worapongpaiboon S
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):187-90. PubMed ID: 12632030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic effect of activated recombinant factor VIIa in Bernard-Soulier syndrome: studies in an in vitro model.
    Tonda R; Galán AM; Pino M; Lozano M; Ordinas A; Escolar G
    Transfusion; 2004 Dec; 44(12):1790-1. PubMed ID: 15584995
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of recombinant factor VII in Glanzmann thrombasthenia: a case report].
    Chabchoub Ben Abdallah R; Trabelsi L; Ben Ameur S; Kammoun F; Boukédi A; Ben Salah M; Ben Hlima N; Mahfoudh A
    Arch Pediatr; 2010 Jul; 17(7):1062-4. PubMed ID: 20570498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
    Tefre KL; Ingerslev J; Sørensen B
    Haemophilia; 2009 Jan; 15(1):281-4. PubMed ID: 19149853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In process].
    Koczorek M
    Med Monatsschr Pharm; 2016 Sep; 39(9):400-1. PubMed ID: 29956518
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa.
    Chuansumrit A; Sangkapreecha C; Hathirat P
    Thromb Haemost; 1999 Dec; 82(6):1778. PubMed ID: 10613676
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet function defects.
    Simon D; Kunicki T; Nugent D
    Haemophilia; 2008 Nov; 14(6):1240-9. PubMed ID: 19141164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath.
    Ancliff P; Liesner R; Khair K; Hann I
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):447-8. PubMed ID: 10695773
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
    Gunaydin B; Ozkose Z; Pezek S
    J Anesth; 2007; 21(1):106-7. PubMed ID: 17285428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.